NO20070521L - Fremgangsmater relatert til en enkel nukleotid polymorfisme av den G-proteinkoplede reseptor, GPR40 - Google Patents

Fremgangsmater relatert til en enkel nukleotid polymorfisme av den G-proteinkoplede reseptor, GPR40

Info

Publication number
NO20070521L
NO20070521L NO20070521A NO20070521A NO20070521L NO 20070521 L NO20070521 L NO 20070521L NO 20070521 A NO20070521 A NO 20070521A NO 20070521 A NO20070521 A NO 20070521A NO 20070521 L NO20070521 L NO 20070521L
Authority
NO
Norway
Prior art keywords
gpr40
single nucleotide
nucleotide polymorphism
coupled receptor
protein coupled
Prior art date
Application number
NO20070521A
Other languages
English (en)
Inventor
Poulabi Banerjee
Karen Lynne Houseknecht
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20070521L publication Critical patent/NO20070521L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Denne oppfinnelsen er relatert til fremgangsmåter av genotyping, fremgangsmåter for behandling, diagnostiske tester og fremgangsmåter for å karakterisere et middel, relatert til en enkel nukleotid polymorfisme av GPR40-genet.
NO20070521A 2004-06-30 2007-01-26 Fremgangsmater relatert til en enkel nukleotid polymorfisme av den G-proteinkoplede reseptor, GPR40 NO20070521L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US58468604P 2004-06-30 2004-06-30
US11/046,020 US20060003344A1 (en) 2004-06-30 2005-01-28 Methods related to a single nucleotide polymorphism of the G protein coupled receptor, GPR40
PCT/IB2005/001962 WO2006006062A1 (en) 2004-06-30 2005-06-20 Methods related to a single nucleotide polymorphism of the g protein coupled receptor, gpr40

Publications (1)

Publication Number Publication Date
NO20070521L true NO20070521L (no) 2007-01-26

Family

ID=35514424

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20070521A NO20070521L (no) 2004-06-30 2007-01-26 Fremgangsmater relatert til en enkel nukleotid polymorfisme av den G-proteinkoplede reseptor, GPR40

Country Status (10)

Country Link
US (1) US20060003344A1 (no)
EP (1) EP1763585A1 (no)
JP (1) JP2008504836A (no)
AU (1) AU2005261437A1 (no)
BR (1) BRPI0512745A (no)
CA (1) CA2570921A1 (no)
IL (1) IL179911A0 (no)
MX (1) MXPA06014024A (no)
NO (1) NO20070521L (no)
WO (1) WO2006006062A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0934061T6 (en) 1996-07-24 2015-01-26 Warner Lambert Co Isobutylgaba and its derivatives for the treatment of pain
CA2558585C (en) * 2004-02-27 2010-10-12 Amgen Inc. Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders
US7465804B2 (en) * 2005-05-20 2008-12-16 Amgen Inc. Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders
US7582803B2 (en) * 2005-09-14 2009-09-01 Amgen Inc. Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disorders
MX2008011615A (es) * 2006-03-14 2008-09-22 Amgen Inc Derivados de acidos carboxilicos biciclicos utiles para tratar trastornos metabolicos.
EP2064193A1 (en) * 2006-09-07 2009-06-03 Amgen, Inc Heterocyclic gpr40 modulators
WO2008030618A1 (en) * 2006-09-07 2008-03-13 Amgen Inc. Benzo-fused compounds for use in treating metabolic disorders
JP2008195625A (ja) * 2007-02-08 2008-08-28 Pharma Frontier Kk Ｇ蛋白質共役型レセプター抑制剤および医薬
US7572934B2 (en) * 2007-04-16 2009-08-11 Amgen Inc. Substituted biphenyl GPR40 modulators
BRPI0818253A2 (pt) 2007-10-10 2015-04-07 Amgen Inc Moduladores de gpr40 bifenil substituídos
JP2011515341A (ja) * 2008-03-06 2011-05-19 アムジエン・インコーポレーテツド 代謝障害の治療に有用な立体配座的に制限されたカルボン酸誘導体
CA2739888C (en) * 2008-10-15 2013-11-19 Amgen Inc. Spirocyclic gpr40 modulators
US10172916B2 (en) 2013-11-15 2019-01-08 The Board Of Trustees Of The Leland Stanford Junior University Methods of treating heart failure with agonists of hypocretin receptor 2

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0031527D0 (en) * 2000-12-22 2001-02-07 Smithkline Beecham Plc New use
WO2003068959A1 (fr) * 2002-02-14 2003-08-21 Takeda Chemical Industries, Ltd. Nouveau procede de criblage

Also Published As

Publication number Publication date
AU2005261437A1 (en) 2006-01-19
EP1763585A1 (en) 2007-03-21
IL179911A0 (en) 2007-05-15
WO2006006062A1 (en) 2006-01-19
BRPI0512745A (pt) 2008-04-08
JP2008504836A (ja) 2008-02-21
MXPA06014024A (es) 2007-02-08
US20060003344A1 (en) 2006-01-05
CA2570921A1 (en) 2006-01-19

Similar Documents

Publication Publication Date Title
NO20070521L (no) Fremgangsmater relatert til en enkel nukleotid polymorfisme av den G-proteinkoplede reseptor, GPR40
MX2013006669A (es) Conjunto de sondas de oligonucleotido y metodos para perfilado de microbiotica.
GB2457402B (en) Four-color DNA sequencing by synthesis using cleavable fluorescent nucleotide reversible terminators
NO20081883L (no) Modulasjon av glukokortikoidreseptorekspresjon
WO2008039769A3 (en) Methods and devices for analyzing small rna molecules
WO2009113779A3 (ko) Ｓｎｐ 어레이를 이용한 염색체, 유전자, 또는 특정 뉴클레오티드 서열의 카피 수 측정방법
MX2007009809A (es) Amplificacion de sonda por seleccion.
TW200608961A (en) Methods and reagents for the treatment of metabolic disorders
HK1092841A1 (en) Compositions, reagents and kits for and methods of diagnosing, monitoring and treating obesity and /or diabetes
ATE539170T1 (de) Abschätzung und verringerung des risikos von graft-versus-host-reaktion
SG170802A1 (en) Systems and devices for sequence by synthesis analysis
WO2007047408A3 (en) Promac signature application
NO20083011L (no) Modulatorer av muskarine receptorer
BRPI0520067A2 (pt) desenvolvimento de um ensaio de pcr em tempo real para a detecção de dna pneumocócico e diagnóstico da doença pneumocócica
NO20083204L (no) Kombinasjon av en H3-antagonist/inversagonist og en appetittdemper
NO20070949L (no) Transkriptomdiagnostikk i spytt
ATE526585T1 (de) Natürlicher ligand des g-protein-gekoppelten rezeptors rcc356 und verwendungen davon
DE602005020592D1 (de) Cpg-amplicon und array-protokoll
CY1110076T1 (el) Μεθοδος για τον καθορισμο της δεκτικοτητας σε αναστολεις chk1
NO20073636L (no) Sammensetninger og metoder til a behandle mentale lidelser
WO2007120955A3 (en) Genes affecting human memory performance
DE602004030367D1 (de) Diagnostikum für osteoporose
ATE447628T1 (de) Einzelsequenzhybridisierungssonden
WO2005056839A3 (de) Primer und sonden zum nachweis genitaler hpv-genotypen
NO20070780L (no) Celloverflateprotein.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application